RE:RE:Nextleaf 2020 - 2021 revenueYellowBrickRoad wrote: Dividing revenue by number of shares and then finding price multiple, here are numbers from LABS:
Date | Revenue | Rev/Share | Share Price | Price/Rev |
3/29/2019 | $21,950.00 | $0.37 | $3.34 | 9.03 |
6/28/2019 | $31,472.00 | $0.24 | $5.18 | 21.58 |
Here is where OILS would be with those multiples and comparing to $0.20 RPS using an undiluted share count:
Revenue | Shares | Rev/Share | 9 x Multiple | 21 x Multiple |
$35,000,000 | 108,120,000 | $0.32 | $2.91 | $6.80 |
$21,624,000 | 108,120,000 | $0.20 | $1.80 | $4.20 |
If we add Ubika's revenue projection for 2021 using the above metrics we get:
Revenue | Shares | Rev/Share | 9 x Multiple | 21 x Multiple |
$35,000,000 | 108,120,000 | $0.32 | $2.91 | $6.80 |
$21,624,000 | 108,120,000 | $0.20 | $1.80 | $4.20 |
$119,000,000 | 108,120,000 | $1.10 | $9.91 | $23.11 |
It depends on what multiple the market settles on. LABS quarterly results are coming out soon, we'll see what the multiple is for their Q3.